Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease
Clinical trial NCT05623501 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05623501
- Sponsor
- University of Southern California
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-15
- Primary completion
- 2025-12-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.